Profile data is unavailable for this security.
About the company
Chongqing Taiji Industry Group Co Ltd is a China-based company that is primarily engaged in the production and sale of Chinese and Western medicines. The company operates four segments. Pharmaceutical Industry segment mainly produces Chinese patent medicines and Western medicines. Pharmaceutical Business segment mainly includes pharmaceutical distribution and retail. The Company also operates Chinese herbal medicine resource segment and Service and Other segment. The Company's products include digestive system and metabolic drugs, respiratory system drugs, cardiovascular and cerebrovascular drugs, anti-infective drugs, nervous system drugs, anti-tumor and immune regulation drugs, and health products. The Company mainly operates its businesses in the domestic market.
- Revenue in CNY (TTM)15.40bn
- Net income in CNY834.00m
- Incorporated1993
- Employees12.59k
- LocationChongqing Taiji Industry Group Co LtdNo.18Hengshan East Road, Yubei DistrictCHONGQING 401121ChinaCHN
- Phone+86 2 389886129
- Fax+86 2 389887399
- Websitehttp://www.taiji.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 12.54bn | 3.36k | 630.77 | 0.4301 | -- | 1.12 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 386.57m | -260.85m | 13.35bn | 867.00 | -- | 8.38 | -- | 34.55 | -1.00 | -1.00 | 1.49 | 6.02 | 0.1621 | 0.2594 | 3.75 | 445,874.00 | -11.74 | -27.13 | -20.82 | -39.20 | 92.29 | 92.75 | -72.40 | -220.71 | 2.15 | -- | 0.3842 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.30bn | 734.24m | 13.89bn | 4.01k | 18.94 | 3.37 | -- | 3.23 | 1.17 | 1.17 | 6.83 | 6.55 | 0.6698 | 4.34 | 13.62 | 1,071,799.00 | 12.35 | 10.82 | 18.82 | 15.08 | 64.01 | 65.02 | 18.44 | 18.17 | 1.47 | -- | 0.0061 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Chongqing Taiji Industry Group Co Ltd | 15.40bn | 834.00m | 14.45bn | 12.59k | 17.33 | 3.73 | -- | 0.9382 | 1.50 | 1.50 | 27.66 | 6.95 | 1.03 | 3.15 | 5.84 | 1,223,535.00 | 5.77 | 0.7814 | 17.83 | 2.35 | 46.14 | 44.03 | 5.62 | 0.8498 | 0.5315 | 6.12 | 0.5393 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Jiangsu Sinopep Allsin Bphrmctcl Co Ltd | 1.18bn | 208.25m | 14.46bn | 1.55k | 67.83 | 6.28 | -- | 12.24 | 0.9769 | 0.9769 | 5.54 | 10.55 | 0.3743 | 1.21 | 4.71 | 764,598.40 | 6.69 | 5.86 | 9.15 | 7.59 | 63.15 | 55.41 | 17.87 | 17.20 | 1.08 | 33.77 | 0.3356 | 27.59 | 58.69 | 32.24 | 26.20 | 29.99 | 27.32 | -- |
| Tonghua Dongbao Pharmaceutical Co Ltd | 3.00bn | 1.13bn | 15.44bn | 3.20k | 13.71 | 2.09 | -- | 5.14 | 0.5682 | 0.5682 | 1.51 | 3.73 | 0.403 | 0.8622 | 4.57 | 939,125.30 | 15.20 | 18.68 | 15.84 | 19.68 | 79.89 | 78.73 | 37.71 | 39.20 | 5.04 | -- | 0.03 | 41.73 | 10.69 | 2.69 | -26.17 | 6.85 | -14.75 | 4.56 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 15.77bn | 11.61k | 18.39 | 1.24 | -- | 1.34 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
Data as of Jul 29 2024. Currency figures normalised to Chongqing Taiji Industry Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
17.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 18.62m | 3.34% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 31 Dec 2023 | 14.68m | 2.64% |
| GF Fund Management Co., Ltd.as of 30 Sep 2023 | 8.96m | 1.61% |
| China Asset Management Co., Ltd.as of 31 Mar 2024 | 8.65m | 1.55% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.47m | 1.52% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 8.20m | 1.47% |
| Minsheng Royal Fund Management Co., Ltd.as of 31 Dec 2023 | 8.11m | 1.46% |
| Bosera Asset Management Co., Ltd.as of 31 Dec 2023 | 7.88m | 1.41% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 7.83m | 1.41% |
| CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 7.17m | 1.29% |
More ▼
Data from 31 Dec 2023 - 24 Jul 2024Source: FactSet Research Systems Inc.
